Noninvasive optical tracking of red fluorescent protein-expressing cancer cells in a model of metastatic breast cancer
- PMID: 17032496
- PMCID: PMC1715931
- DOI: 10.1593/neo.06304
Noninvasive optical tracking of red fluorescent protein-expressing cancer cells in a model of metastatic breast cancer
Erratum in
-
Corrigendum to: "Noninvasive Optical Tracking of Red Fluorescent Protein-Expressing Cancer Cells in a Model of Metastatic Breast Cancer" by Paul T. Winnard Jr., Jessica B. Kluth, and Venu Raman published in Neoplasia, volume 8, number 10, October 2006, on pages 796-806.Neoplasia. 2016 May;18(5):328. doi: 10.1016/j.neo.2016.03.006. Epub 2016 May 26. Neoplasia. 2016. PMID: 27237324 Free PMC article. No abstract available.
Abstract
We have evaluated the use of the Xenogen IVIS 200 imaging system for real-time fluorescence protein-based optical imaging of metastatic progression in live animals. We found that green fluorescent protein-expressing cells (100 x 10(6)) were not detectable in a mouse cadaver phantom experiment. However, a 10-fold lower number of tdTomato-expressing cells were easily detected. Mammary fat pad xenografts of stable MDA-MB-231-tdTomato cells were generated for the imaging of metastatic progression. At 2 weeks postinjection, barely palpable tumor burdens were easily detected at the sites of injection. At 8 weeks, a small contralateral mammary fat pad metastasis was imaged and, by 13 weeks, metastases to lymph nodes were detectable. Metastases with nodular composition were detectable within the rib cage region at 15 weeks. 3-D image reconstructions indicated that the detection of fluorescence extended to approximately 1 cm below the surface. A combination of intense tdTomato fluorescence, imaging at > or = 620 nm (where autofluorescence is minimized), and the sensitivity of the Xenogen imager made this possible. This study demonstrates the utility of the noninvasive optical tracking of cancer cells during metastatic progression with endogenously expressed fluorescence protein reporters using detection wavelengths of > or = 620 nm.
Figures
References
-
- Shaner NC, Campbell RE, Steinbach PA, Giepmans BN, Palmer AE, Tsien RY. Improved monomeric red, orange and yellow fluorescent proteins derived form Discosoma sp. red fluorescent protein. Nat Biotechnol. 2004;22:1567–1572. - PubMed
-
- Doubrovin M, Serganova I, Mayer-Kuckuk P, Ponomarev V, Blasberg RG. Multimodality in vivo molecular-genetic imaging. Bioconjug Chem. 2004;15:1376–1388. - PubMed
-
- Chudakov DM, Lukyanov S, Lukyanov KA. Fluorescent proteins as a toolkit for in vivo imaging. Trends Biotechnol. 2005;23:605–613. - PubMed
-
- Henriksson KC, Almgren MAE, Thurlow R, Varki NM, Chang CL. A fluorescent orthotopic mouse model for reliable measurement and genetic modulation of human neuroblastoma metastasis. Clin Exp Metastasis. 2004;21:563–570. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous